Literature DB >> 23091431

Will comparative effectiveness research finally succeed?

Erwin A Blackstone, Joseph P Fuhr, Danielle Ziernicki.   

Abstract

Autonomy, innovation, and drug access may be at stake along with personalized medicine. Can all stakeholders be satisfied and should cost be a factor?

Year:  2012        PMID： 23091431      PMCID： PMC3474453     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  16 in total

1.  Does comparative-effectiveness research threaten personalized medicine?

Authors:  Alan M Garber; Sean R Tunis
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

2.  Comparative effectiveness research.

Authors:  Anthony N Demaria
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

3.  Comparative-effectiveness research--implications of the Federal Coordinating Council's report.

Authors:  Patrick H Conway; Carolyn Clancy
Journal:  N Engl J Med       Date:  2009-06-30       Impact factor: 91.245

4.  Comparative effectiveness research: a report from the Institute of Medicine.

Authors:  Harold C Sox; Sheldon Greenfield
Journal:  Ann Intern Med       Date:  2009-06-30       Impact factor: 25.391

5.  Variations in the use of medical and surgical services by the Medicare population.

Authors:  M R Chassin; R H Brook; R E Park; J Keesey; A Fink; J Kosecoff; K Kahn; N Merrick; D H Solomon
Journal:  N Engl J Med       Date:  1986-01-30       Impact factor: 91.245

Review 6.  An introduction to comparative effectiveness research.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

7.  The neglected purpose of comparative-effectiveness research.

Authors:  Aanand D Naik; Laura A Petersen
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

8.  Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society.

Authors:  Roger Chou; Amir Qaseem; Vincenza Snow; Donald Casey; J Thomas Cross; Paul Shekelle; Douglas K Owens
Journal:  Ann Intern Med       Date:  2007-10-02       Impact factor: 25.391

9.  Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.

Authors:  Mark H Eckman; Jonathan Rosand; Steven M Greenberg; Brian F Gage
Journal:  Ann Intern Med       Date:  2009-01-20       Impact factor: 25.391

10.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

Authors:  Mark A Hlatky; Derek B Boothroyd; Dena M Bravata; Eric Boersma; Jean Booth; Maria M Brooks; Didier Carrié; Tim C Clayton; Nicolas Danchin; Marcus Flather; Christian W Hamm; Whady A Hueb; Jan Kähler; Sheryl F Kelsey; Spencer B King; Andrzej S Kosinski; Neuza Lopes; Kathryn M McDonald; Alfredo Rodriguez; Patrick Serruys; Ulrich Sigwart; Rodney H Stables; Douglas K Owens; Stuart J Pocock
Journal:  Lancet       Date:  2009-03-19       Impact factor: 79.321
View more
  2 in total

1.  The landscape of comparative effectiveness research in rheumatology.

Authors:  Esi Morgan DeWitt; Hermine I Brunner
Journal:  Nat Rev Rheumatol       Date:  2013-09-24       Impact factor: 20.543

Review 2.  Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges.

Authors:  Richard Ofori-Asenso; Christine E Hallgreen; Marie Louise De Bruin
Journal:  Front Med (Lausanne)       Date:  2020-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.